Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,310,073
-
Share change
-
+174,813
-
Total reported value
-
$34,262,000
-
Price per share
-
$7.95
-
Number of holders
-
22
-
Value change
-
+$1,392,179
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q2 2016
As of 30 Jun 2016,
RECRO PHARMA INC - COM (SCTL) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,310,073 shares.
The largest 10 holders included
Broadfin Capital, LLC, Cormorant Asset Management, LLC, Tourbillon Capital Partners, L.P., Stonepine Capital Management, LLC, VANGUARD GROUP INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BB&T CORP, BlackRock Institutional Trust Company, N.A., Spark Investment Management LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.